Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-7-30
pubmed:databankReference
pubmed:abstractText
Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease. There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
2009 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
30
pubmed:volume
361
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
455-67
pubmed:dateRevised
2009-10-29
pubmed:meshHeading
pubmed-meshheading:19641202-Administration, Oral, pubmed-meshheading:19641202-Adolescent, pubmed-meshheading:19641202-Adult, pubmed-meshheading:19641202-Animals, pubmed-meshheading:19641202-Antimalarials, pubmed-meshheading:19641202-Artemisinins, pubmed-meshheading:19641202-Drug Resistance, pubmed-meshheading:19641202-Drug Therapy, Combination, pubmed-meshheading:19641202-Follow-Up Studies, pubmed-meshheading:19641202-Humans, pubmed-meshheading:19641202-Hypoxanthine, pubmed-meshheading:19641202-Inhibitory Concentration 50, pubmed-meshheading:19641202-Malaria, Falciparum, pubmed-meshheading:19641202-Mefloquine, pubmed-meshheading:19641202-Multidrug Resistance-Associated Proteins, pubmed-meshheading:19641202-Plasmodium falciparum, pubmed-meshheading:19641202-Polymorphism, Genetic, pubmed-meshheading:19641202-Recurrence, pubmed-meshheading:19641202-Young Adult
pubmed:year
2009
pubmed:articleTitle
Artemisinin resistance in Plasmodium falciparum malaria.
pubmed:affiliation
Mahidol Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. arjen@tropmedres.ac
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study